KIORA PHARMACEUTICALS, INC. Fair Value Adjustment of Warrants
KIORA PHARMACEUTICALS, INC. (KPRX) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-25.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2024-03-25
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2022-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for the quarter ending 2022-09-30 was $1.43M.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2022 was $1.43M.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2021 was $0.00.
- KIORA PHARMACEUTICALS, INC. fair value adjustment of warrants for fiscal 2016 was $0.00.
| Period end | Fair Value Adjustment of Warrants | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 9 month as first filed | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $1.43M derived: sum of 2 quarters · filed 2024-03-25 | $1.43M 10-K · filed 2024-03-25 | |||
| 2022-09-30 | $1.43M 10-Q · filed 2023-11-09 | $1.43M 10-Q · filed 2023-11-09 | $2.25M 10-Q · filed 2022-11-09 | |||
| 2022-09-23 | $1.43M 10-Q · filed 2022-11-09 | |||||
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 | |||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 | ||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-10 | $0.00 10-Q · filed 2016-08-10 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | $0.00 derived: sum of 4 quarters · filed 2017-02-23 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 derived: sum of 2 quarters · filed 2017-02-23 | $0.00 derived: sum of 3 quarters · filed 2017-02-23 | -$223.17K 10-K · filed 2017-02-23 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 | $0.00 derived: sum of 2 quarters · filed 2016-11-01 | -$223.17K 10-Q · filed 2016-11-01 | -$441.70K derived: sum of 4 quarters · filed 2016-11-01 | ||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-10 | -$223.17K 10-Q · filed 2016-08-10 | -$441.70K derived: sum of 3 quarters · filed 2016-08-10 | -$1.32M derived: sum of 4 quarters · filed 2016-08-10 | ||
| 2015-03-31 | -$223.17K 10-Q · filed 2016-05-13 | -$441.70K derived: sum of 2 quarters · filed 2016-05-13 | -$1.32M derived: sum of 3 quarters · filed 2016-05-13 | -$1.32M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | -$218.53K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.10M derived: sum of 2 quarters · filed 2016-03-30 | -$1.10M derived: sum of 3 quarters · filed 2016-03-30 | -$1.10M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | -$881.75K 10-Q · filed 2015-11-12 | -$876.75K derived: sum of 2 quarters · filed 2015-11-12 | -$876.75K 10-Q · filed 2015-11-12 | |||
| 2014-06-30 | $5.00K 10-Q · filed 2015-08-12 | $5.00K 10-Q · filed 2015-08-12 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |